Is insulin treatment a first-line defense against Type 2 diabetes?

Expert Rev Cardiovasc Ther. 2010 Apr;8(4):483-5. doi: 10.1586/erc.10.26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / pharmacology
  • Insulin / therapeutic use*
  • Patient Acceptance of Health Care
  • Time Factors

Substances

  • Hypoglycemic Agents
  • Insulin